Advertisement

Topics

RedHill Biopharma nets $23.7mm through FOPO

15:40 EDT 10 Aug 2018 | Elsevier Business Intelligence

RedHill Biopharma Ltd. netted $23.7mm in a public offering of 4.2mm American Depositary Shares (ADSs) at $6 per ADS. (Each AD...

Original Article: RedHill Biopharma nets $23.7mm through FOPO

NEXT ARTICLE

More From BioPortfolio on "RedHill Biopharma nets $23.7mm through FOPO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Crohn's Disease (CD)
Crohn’s disease (CD) is a long-term condition that causes inflammation of the lining of the digestive system.  Inflammation can affect any part of the digestive system, from the mouth to the back passage, but most commonly occurs in the last s...